PAVmed (PAVM) Short Interest Ratio & Short Volume $0.72 -0.04 (-5.26%) (As of 12/16/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAVmed Short Interest DataPAVmed (PAVM) has a short interest of 286,500 shares, representing 3.12% of the float (the number of shares available for trading by the public). This marks a 6.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 68,546 shares to cover all short positions.Current Short Interest286,500 sharesPrevious Short Interest269,900 sharesChange Vs. Previous Month+6.15%Dollar Volume Sold Short$277,905.00Short Interest Ratio4.4 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares11,070,000 sharesFloat Size9,190,000 sharesShort Percent of Float3.12%Today's Trading Volume71,872 sharesAverage Trading Volume68,546 sharesToday's Volume Vs. Average105% Short Selling PAVmed? Sign up to receive the latest short interest report for PAVmed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPAVM Short Interest Over TimePAVM Days to Cover Over TimePAVM Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now PAVmed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024286,500 shares $277,905.00 +6.2%3.1%4.4 $0.97 11/15/2024269,900 shares $307,686.00 -4.0%2.9%4.1 $1.14 10/31/2024281,000 shares $300,670.00 +1.4%3.3%4.6 $1.07 10/15/2024277,100 shares $279,871.00 +2.5%3.2%4.1 $1.01 9/30/2024270,400 shares $332,592.00 +0.4%3.1%3.5 $1.23 9/15/2024269,400 shares $479,532.00 -8.2%2.9%3.4 $1.78 Get the Latest News and Ratings for PAVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024293,400 shares $266,994.00 +19.0%3.2%3.6 $0.91 8/15/2024246,600 shares $172,866.60 +3.6%2.7%3.8 $0.70 7/31/2024238,100 shares $205,944.60 -9.8%2.9%3.7 $0.86 7/15/2024264,100 shares $248,254.00 No Change3.2%4.1 $0.94 2/29/2024356,400 shares $944,460.00 -10.1%5.4%4.3 $2.65 2/15/2024396,500 shares $787,052.50 +44.5%5.4%5.2 $1.99 1/31/2024274,400 shares $636,608.00 -10.8%3.8%3.9 $2.32 1/15/2024307,700 shares $1.01 million +14.9%3.8%4.8 $3.29 12/31/2023267,700 shares $1.10 million -1.5%3.7%4.8 $4.12 12/15/2023271,700 shares $1.01 million +27.2%3.7%5.7 $3.72 11/30/2023213,600 shares $990,036.00 -93.5%3.0%4.8 $4.64 11/15/20233,270,000 shares $722,670.00 -9.4%N/A5.1 $0.22 10/31/20233,610,000 shares $943,293.00 -1.4%N/A5.2 $0.26 10/15/20233,660,000 shares $1.08 million +9.6%N/A5.2 $0.29 9/30/20233,340,000 shares $983,964.00 -8.2%N/A4.7 $0.29 9/15/20233,640,000 shares $1.16 million -10.3%N/A4.9 $0.32 8/31/20234,060,000 shares $1.27 million +1.5%N/A6.1 $0.31 8/15/20234,000,000 shares $1.22 million +2.3%N/A7.6 $0.31 7/31/20233,910,000 shares $1.47 million -7.1%N/A8.2 $0.38 7/15/20234,210,000 shares $1.64 million -4.5%N/A8.6 $0.39 6/30/20234,410,000 shares $1.80 million +4.8%N/A8.5 $0.41 6/15/20234,210,000 shares $1.76 million -8.5%N/A8.5 $0.42 5/31/20234,600,000 shares $1.85 million -8.6%N/A9.6 $0.40 5/15/20235,030,000 shares $2.54 million -2.3%N/A12 $0.50 4/30/20235,150,000 shares $2.27 million -5.9%N/A11.5 $0.44 4/15/20235,470,000 shares $2.41 million -1.8%N/A12.3 $0.44 3/31/20235,570,000 shares $2.08 million -21.9%6.7%12.2 $0.37 3/15/20237,130,000 shares $3.07 million -3.1%8.5%13.9 $0.43 2/28/20237,360,000 shares $3.41 million +14.8%9.2%13.2 $0.46 2/15/20236,410,000 shares $3.08 million +8.1%8.1%10.4 $0.48 1/31/20235,930,000 shares $3.03 million -11.4%N/A8.7 $0.51 1/15/20236,690,000 shares $3.91 million +13.4%N/A9.5 $0.59 12/30/20225,900,000 shares $2.83 million +8.5%N/A8.6 $0.48 12/15/20225,440,000 shares $2.79 million -0.4%N/A7.7 $0.51Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 11/30/20225,460,000 shares $3.82 million -1.8%N/A8 $0.70 11/15/20225,560,000 shares $5.35 million -5.1%N/A8.9 $0.96 10/31/20225,860,000 shares $7.27 million +3.9%7.1%7.1 $1.24 10/15/20225,640,000 shares $5.55 million +15.6%6.8%5.9 $0.98 9/30/20224,880,000 shares $4.20 million +6.1%5.9%5.2 $0.86 9/15/20224,600,000 shares $5.15 million -1.1%5.6%4.3 $1.12 8/31/20224,650,000 shares $5.53 million -21.3%5.6%4 $1.19 8/15/20225,910,000 shares $13.42 million -9.9%7.2%4.6 $2.27 7/31/20226,560,000 shares $7.94 million +2.2%8.2%5.2 $1.21 7/15/20226,420,000 shares $6.81 million -10.5%8.0%4.3 $1.06 6/30/20227,170,000 shares $6.70 million -25.7%9.0%4.5 $0.93 6/15/20229,650,000 shares $9.15 million +3.4%12.1%5.4 $0.95 5/31/20229,330,000 shares $9.42 million +16.8%11.7%5.2 $1.01 5/15/20227,990,000 shares $8.23 million -2.8%10.0%4.5 $1.03 4/30/20228,220,000 shares $10.44 million +14.5%10.3%4.6 $1.27 4/15/20227,180,000 shares $7.61 million +19.5%9.0%4.6 $1.06 3/31/20226,010,000 shares $7.93 million +10.3%7.7%3.8 $1.32 3/15/20225,450,000 shares $6.43 million -0.7%6.9%3.3 $1.18 2/28/20225,490,000 shares $8.40 million +37.3%7.0%3.3 $1.53 2/15/20224,000,000 shares $7.36 million -5.4%5.1%2.2 $1.84 1/31/20224,230,000 shares $7.28 million -3.9%5.4%2.1 $1.72 1/15/20224,400,000 shares $8.49 million -8.0%5.6%2.1 $1.93 12/31/20214,780,000 shares $11.76 million -15.3%6.1%2 $2.46 12/15/20215,640,000 shares $17.48 million -3.8%7.2%2.4 $3.10 11/30/20215,860,000 shares $21.51 million -2.2%7.5%2.4 $3.67 11/15/20215,990,000 shares $29.35 million -2.0%7.6%2.5 $4.90 10/29/20216,110,000 shares $33.18 million +3.7%8.1%2.7 $5.43 10/15/20215,890,000 shares $35.81 million +13.5%7.8%2.6 $6.08 9/30/20215,190,000 shares $44.32 million +10.0%6.9%2.7 $8.54 9/15/20214,720,000 shares $35.35 million +1.9%6.4%2.6 $7.49 8/31/20214,630,000 shares $33.80 million -6.5%6.2%2.7 $7.30 8/13/20214,950,000 shares $30.44 million -8.0%6.7%2.8 $6.15 7/30/20215,380,000 shares $36.96 million +3.9%7.3%2.9 $6.87 7/15/20215,180,000 shares $27.35 million -0.8%7.1%2.7 $5.28 6/30/20215,220,000 shares $33.41 million -0.2%7.1%2.4 $6.40 6/15/20215,230,000 shares $31.69 million -12.5%7.1%1.7 $6.06 5/28/20215,980,000 shares $31.69 million +16.1%8.1%1.8 $5.30 5/14/20215,150,000 shares $20.50 million -5.9%N/A1.4 $3.98 4/30/20215,470,000 shares $25.71 million +6.0%N/A1.1 $4.70 4/15/20215,160,000 shares $25.21 million -12.8%N/A1 $4.89 3/31/20215,920,000 shares $27.41 million +8.2%N/A1.3 $4.63 3/15/20215,470,000 shares $23.74 million -1.8%N/A1.3 $4.34 2/26/20215,570,000 shares $24.90 million +6.5%N/A1.4 $4.47 2/12/20215,230,000 shares $16.79 million +10.3%N/A1.5 $3.21 1/29/20214,740,000 shares $9.76 million -2.5%N/A2.5 $2.06 1/15/20214,860,000 shares $10.06 million +13.6%N/A2.9 $2.07 12/31/20204,280,000 shares $9.03 million +18.9%N/A3 $2.11 12/15/20203,600,000 shares $6.37 million -2.7%N/A3.6 $1.77 11/30/20203,700,000 shares $7.25 million +15.6%N/A6.4 $1.96 11/15/20203,200,000 shares $5.76 million +2.9%N/A5.6 $1.80Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. 10/30/20203,110,000 shares $5.75 million -4.9%N/A5.5 $1.85 10/15/20203,270,000 shares $6.47 million -8.2%N/A5.6 $1.98 9/30/20203,560,000 shares $6.34 million -11.4%N/A6 $1.78 9/15/20204,020,000 shares $7.56 million +0.8%N/A5.7 $1.88 8/31/20203,990,000 shares $7.86 million +11.1%N/A4.9 $1.97 8/14/20203,590,000 shares $7.79 million -8.0%N/A4.1 $2.17 7/31/20203,900,000 shares $7.76 million +1.8%N/A4.2 $1.99 7/15/20203,830,000 shares $8.00 million +6.1%N/A3.9 $2.09 6/30/20203,610,000 shares $7.62 million +27.1%N/A3.3 $2.11 6/15/20202,840,000 shares $5.51 million +29.7%N/A2.8 $1.94 5/29/20202,190,000 shares $4.36 million +9.5%N/A2.1 $1.99 5/15/20202,000,000 shares $4.54 million No ChangeN/A1.8 $2.27 4/30/20202,000,000 shares $4.38 million +13.6%6.2%1.5 $2.19 4/15/20201,760,000 shares $4.14 million +36.4%5.8%1.4 $2.35 3/31/20201,290,000 shares $3.19 million -32.3%4.3%1 $2.47 3/13/20201,904,600 shares $3.64 million -16.1%7.3%1.5 $1.91 2/28/20202,270,000 shares $3.13 million +159.0%8.7%1.9 $1.38 2/14/2020876,400 shares $1.91 million +17.2%3.4%0.8 $2.18 1/31/2020748,100 shares $1.98 million -10.1%2.9%1.1 $2.65 1/15/2020832,500 shares $1.41 million -10.3%3.1%1.4 $1.69 12/31/2019928,100 shares $1.44 million +65.8%3.5%1.9 $1.55 PAVM Short Interest - Frequently Asked Questions What is PAVmed's current short interest? Short interest is the volume of PAVmed shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 286,500 shares of PAVM short. 3.12% of PAVmed's shares are currently sold short. Learn More on PAVmed's current short interest. What is a good short interest ratio for PAVmed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PAVM shares currently have a short interest ratio of 4.0. Learn More on PAVmed's short interest ratio. What is a good short interest percentage for PAVmed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.12% of PAVmed's floating shares are currently sold short. Is PAVmed's short interest increasing or decreasing? PAVmed saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 286,500 shares, an increase of 6.2% from the previous total of 269,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PAVmed's float size? PAVmed currently has issued a total of 11,070,000 shares. Some of PAVmed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PAVmed currently has a public float of 9,190,000 shares. How does PAVmed's short interest compare to its competitors? 3.12% of PAVmed's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to PAVmed: Beyond Air, Inc. (2.16%), Neuronetics, Inc. (2.00%), Precision Optics Co., Inc. (0.21%), IRIDEX Co. (2.42%), Co-Diagnostics, Inc. (0.72%), Femasys Inc. (2.74%), NEXGEL, Inc. (0.83%), Allurion Technologies Inc. (2.29%), DarioHealth Corp. (5.60%), Vivos Therapeutics, Inc. (2.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short PAVmed stock? Short selling PAVM is an investing strategy that aims to generate trading profit from PAVmed as its price is falling. PAVM shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PAVmed? A short squeeze for PAVmed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PAVM, which in turn drives the price of the stock up even further. How often is PAVmed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAVM, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies XAIR Short Interest STIM Short Interest POCI Short Interest IRIX Short Interest CODX Short Interest FEMY Short Interest NXGL Short Interest ALUR Short Interest DRIO Short Interest VVOS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PAVM) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.